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SUMMARY – Gestational diabetes involves disorder of glucose metabolism first diagnosed in 
pregnancy. Obese women undoubtedly have more often complications in reproductive age, such as 
fertility difficulties, spontaneous and recurrent miscarriages, premature births, and various obstetric 
and surgical complications related to the course of pregnancy, delivery and puerperium. Children of 
obese pregnant women are more likely to develop obesity in childhood and adulthood. We analyzed 
the outcome of 51 pregnancies in obese pregnant women and 50 pregnant women with normal body 
mass index. All women in both groups were diagnosed with gestational diabetes by the IADPSG 
criteria. We analyzed gestational age at delivery and mode of delivery, gestational weight gain,  presence 
of concomitant diagnosis of gestational or chronic hypertension, difference in birth weight, and prev-
alence of hypertrophic newborns. There was no significant difference in gestational age at pregnancy 
termination and in the mode of delivery. There was a significant difference in gestational weight gain, 
number of pregnant women with hypertension, neonatal birth weight and number of hypertrophic 
children. Based on the data presented, we conclude that obesity is an unfavorable factor for pregnancy 
outcome. It also influences birth weight and fetal hypertrophy, as well as gestational weight gain.
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Introduction
The incidence of obesity increases, entailing in-
crease in obesity related complications in pregnancy1,2. 
In 2009 and 2010, the prevalence of obesity was al-
most identical in male and female population, about 
35 percent3. Obese women undoubtedly have more 
often complications in reproductive age, such as fertil-
ity difficulties, spontaneous and recurrent miscarriages, 
premature births, and various obstetric and surgical 
complications related to the course of pregnancy, de-
livery and puerperium1,4. Children of obese pregnant 
women are more likely to develop obesity in childhood 
and later in life5.
Obese pregnant women have a higher incidence of 
gestational diabetes (GD) and hypertension1,4. GD in-
volves disorder of glucose metabolism first diagnosed 
in pregnancy6. The incidence of GD is increasing, rep-
resents a risk factor for unfavorable pregnancy out-
come and can lead to later complications in the moth-
er and the child7. Because these metabolic disorders 
are often found together, the risk of pregnancy compli-
cations is significantly higher1,4. These pregnancies re-
quire shorter obstetric follow up intervals and detailed 
antenatal diagnosis, which increases overall costs1,4,8.
Subjects and Methods
We analyzed the outcome of 51 pregnancies in 
obese pregnant women and 50 pregnant women with 
normal body mass index (BMI). All women in both 
groups had a diagnosis of GD by the IADPSG crite-
ria6,9. We defined obesity according to the World 
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Health Organization classification as BMI ≥30 kg/m2. 
BMI 18.5-24.9 kg/m2 was considered normal10.
We analyzed gestational age at delivery and mode 
of delivery, gestational weight gain, presence of con-
comitant diagnosis of gestational or chronic hyperten-
sion, difference in birth weight and frequency of hy-
pertrophic newborns.
Results were statistically analyzed by SPSS 15.0 for 
Windows, T-test and χ2-test.
Results
Analyzing gestational age at delivery, we found 
that there were no significant differences between the 
groups. Two-thirds of pregnant women from both 
groups gave birth in 38th and 39th week of pregnancy. 
Fig. 1. Comparison of the mode of delivery in women 
with normal body mass index (BMI) and obese women 
(CS = cesarean section).
Fig. 2. Comparison of gestational weight gain in women 
with normal body mass index (BMI) and obese women.
Fig. 3. Presence of hypertension in women with normal 
body mass index (BMI) and obese women.
Fig. 4. Comparison of the mean neonatal birth weight  
in women with normal body mass index (BMI) and obese 
women.
Fig. 5. Hypertrophic newborns in women with normal 
body mass index (BMI) and obese women.
Senka Sabolović Rudman et al. Gestational diabetes and body mass index
Acta Clin Croat, Vol. 58, No. 1, 2019 39
There was no significant difference in the mode of de-
livery between pregnant women with normal BMI 
and obese women (χ2=2.52; df=1; p>0.05) (Fig. 1). 
Gestational weight gain was significantly higher in the 
obese group (t=-4.561; df=99; p<0.01) (Fig. 2). In the 
group of obese women, a significant proportion 
(19.6%) had the diagnosis of gestational or chronic hy-
pertension. There was a significant difference in the 
number of pregnant women with hypertension  be-
tween pregnant women with normal BMI and obese 
women (χ2=10.44; df=1; p<0.01) (Fig. 3).
Neonatal birth weight was higher in newborns of 
obese women as compared with those born to preg-
nant women with normal body weight (t=-3.803; 
df=99; p<0.01) (Fig. 4). Moreover, in the group of 
obese pregnant women, there were 21.6% of hypertro-
phic newborns, while this figure was only 4% in the 
group with normal BMI. There was a significant dif-
ference in the rate of neonatal hypertrophy between 
the two groups (χ2=6.95; df=1; p<0.01) (Fig. 5).
Discussion
In this study, we demonstrated obesity in pregnan-
cy to be associated with an increased risk of many ad-
verse pregnancy outcomes. It is well known that ma-
ternal overweight, obesity and severe obesity increase 
morbidity in both the mother and the newborn, and 
are associated with a variety of adverse pregnancy out-
comes. The prevalence of maternal obesity and GD is 
increasing and becoming a major health problem in 
pregnancy with independent and additive impact on 
obstetric outcome11-13. Maternal obesity and GD share 
common metabolic characteristics such as increased 
insulin resistance, hyperglycemia and hyperinsuline-
mia, and GD may elicit distinct effects on clinical out-
comes independently of obesity11-13. Therefore, exami-
nation of the combined association of these common 
metabolic problems with pregnancy outcome is an 
important issue.
Demographic data of pregnant women have changed 
dramatically over the past decade; more women are 
overweight or obese at conception2. Half of patients 
entering their pregnancy in the US have a BMI ≥25.0 
and therefore qualify as overweight or obese11. Evi-
dence supports association of excessive gestational 
weight gain with pregnancy complications and preg-
nancy outcome, as well as short-term and long-term 
impacts on neonatal outcome11-13. Controversy exists 
about the amount of how much weight, if any, obese 
pregnant women should gain14,15. The gestational 
weight gain guidelines were revised and published in 
2009 by the Institute of Medicine and recommended a 
weight gain of 5-9 kg for obese pregnant women16. 
Gestational weight gain recommendations aim to op-
timize outcomes for the woman and the newborn.
Studies have shown that there is a tendency towards 
increased weight gain for obese pregnant women11-13. 
Accordingly, our results showed a significantly higher 
gestational weight gain in the group of obese pregnant 
women compared to the group with normal BMI. 
Moreover, gestational weight gain, which is recognized 
as an independent risk factor for pregnancy related 
morbidity, was greater than recommended by the Insti-
tute of Medicine in obese pregnant women13,17.
Studies report a positive correlation between gesta-
tional weight gain in obese women and neonatal birth-
weight11-13,18. According to our results, there was a sig-
nificantly higher proportion of hypertrophic newborns 
in the group of obese pregnant women and birth 
weight was also significantly higher in this group. Our 
results are consistent with the studies reporting a con-
nection between maternal obesity and fetal out-
come11-13,18. Moreover, studies have shown that new-
borns of obese women who gained more than recom-
mended weight during pregnancy also had a higher 
rate of meconium stained amniotic fluid, neonatal hy-
poglycemia and congenital malformations, but this 
was not the subject of our research12,18.
According to numerous studies, maternal obesity is 
associated with higher cesarean section rates18-20. In 
our study, we did not determine association between 
obesity and mode of delivery. This can be explained by 
the fact that the control group consisted of pregnant 
women with normal BMI and GD, which may be also 
associated with a higher incidence of cesarean section. 
This is in accordance with the observation of Zilberli-
cht et al., who report higher BMI, maternal hypergly-
cemia and recommended gestational weight gain as 
independent risk contributors to adverse pregnancy 
outcome21. Furthermore, there is a mutual effect of 
these three factors on adverse outcomes21. Numerous 
studies found connection between maternal obesity 
and a higher rate of gestational hypertension12,18,20,22. 
Our results are consistent with the studies reporting a 
connection between maternal obesity and gestational 
hypertension12,18,20,22. This is in accordance with the 
 observation of Scifres et al., who evaluated the associa-
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tion of obesity with pregnancy outcome in women 
with GD. According to their results, obesity was in-
dependently associated with a higher incidence of 
 gestational hypertension and hypertensive disorders 
of pregnancy were significantly increased in obese 
women with weight gain higher than recommended 
when compared with obese women with less weight 
gain22.
Conclusion
Based on the data presented, we conclude that obe-
sity is an unfavorable factor for pregnancy outcome. It 
also influences gestational weight gain, as well as neo-
natal birth weight and fetal hypertrophy.
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Sažetak
ISHOD TRUDNOĆE UZ GESTACIJSKI DIJABETES  
U USPOREDBI S INDEKSOM TJELESNE MASE
S. Sabolović Rudman, I. Djaković, V. Gall, Ž. Djaković i V. Košec
Gestacijski dijabetes podrazumijeva poremećaj metabolizma glukoze koji se prvi puta dijagnosticira u trudnoći, a njego-
va incidencija je u porastu. Pretile žene nedvojbeno imaju češće probleme i komplikacije u reproduktivnim godinama, što 
podrazumijeva teškoće pri zanošenju, spontane i habitualne pobačaje, prijevremene porođaje i različite opstetričke i kirurške 
komplikacije vezane za tijek trudnoće, porođaja i babinja. Djeca iz takvih trudnoća češće razvijaju pretilost u djetinjstvu kao 
i u odrasloj dobi. S obzirom na navedeno analizirali smo ishod trudnoća u 51 pretile trudnice i 50 trudnica s urednim in-
deksom tjelesne mase, pri čemu su sve trudnice (u objema skupinama) imale dijagnozu gestacijskog dijabetesa prema krite-
rijima IADPSG. Analizirali smo gestacijsku dob, način dovršenja trudnoće, prirast na težini trudnica, prisutnost istodobnih 
dijagnoza gestacijske ili kronične hipertenzije, razliku u težini novorođenčadi te učestalost hipertrofične novorođenčadi. 
Rezultati su pokazali da ne postoji statistički značajna razlika u gestacijskoj dobi kad je završena trudnoća niti u načinu 
 dovršenja porođaja. Utvrđena je statistički značajna razlika u dobivenim kilogramima tijekom trudnoće, broju trudnica s 
 hipertenzijom, porođajnoj masi novorođenčadi i broju hipertrofične djece. U zaključku, pretilost u  trudnoći s gestacijskim 
dijabetesom je nepovoljan čimbenik za ishod trudnoće, porođajnu masu i prekomjeran rast novorođenčadi, kao i za prirast 
tjelesne mase trudnice tijekom trudnoće.
Ključne riječi: Dijabetes, gestacijski; Hipertenzija uzrokovana trudnoćom; Pretilost; Trudnoća, ishod; Porođaj – metode; Poro-
đajna težina; Hipertrofija
